Biz Briefs

Global Crossing agrees to acquire Impsat for $95 million, or $9.32 a share.

DOV Pharmaceutical has been delisted from the NASDAQ effective tomorrow at the start of business.

Cranbury-based drug manufacturer VaxInnate says it secured $40 million in Series C financing.

Vornado Realty Trust in Paramus entered a 50/50 joint venture with New York-based Gale International to redevelop property to be bought from Federated Department Stores

Experts see little industry-wide impact from the collapse of Kara Homes

Life sciences company Cambrex in East Rutherford entered into a stock purchase agreement for the sale of its biopharma and bioproducts subsidiaries to Swiss life sciences company Lonza Group for $460 million cash

Barr Pharmaceuticals in Woodcliff Lake completes its purchase of Croatia-based PLIVA

Infrared technology typically used on commercial properties enters luxury home market

Industry Report

New Brunswick-based Arbinet (NASDAQ:ARBX) is looking at a number of options to increase its value to its shareholders. These include revising its business plan and selling or merging the company. Shares of Arbinet were up $0.11 to $5.26 in early afternoon trading.

The NJBIZ Interview - Thomas Duffy